Cargando…

RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer

Cyclooxygenases (particularily Cox-2) are involved in carcinogenesis and metastatic cancer progression. The expression profiles of the cyclooxygenases and the roles they play in established tumours of similar stage remains unclear. We report that Cox-1 and Cox-2 expression is highly variable in Duke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Church, R D, Yu, J, Fleshman, J W, Shannon, W D, Govindan, R, McLeod, H L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747709/ https://www.ncbi.nlm.nih.gov/pubmed/15328521 http://dx.doi.org/10.1038/sj.bjc.6602119

Ejemplares similares

Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
por: Glasgow, S C, et al.
Publicado: (2005)

Endometritis in the bitch: Immunohistochemical localization of cyclooxygenase 2
por: Mitacek, María Carla García, et al.
Publicado: (2020)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Knowledge and attitudes of lower Michigan primary care physicians towards dietary interventions: A cross-sectional survey
por: McLeod, Megan R., et al.
Publicado: (2022)

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Ahn, J, et al.
Publicado: (2009)

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
por: Pourbakht, Akram
Publicado: (2013)

The Effects of Cyclooxygenase Inhibitors on the Brain Inflammatory Response Following Traumatic Brain Injury in Rats
por: keshavarzi, Zakieh, et al.
Publicado: (2012)

Desmocollin switching in colorectal cancer
por: Khan, K, et al.
Publicado: (2006)

Keeping an eye on pink eye: a global conjunctivitis outbreak expert survey
por: Kaur, Gurbani, et al.
Publicado: (2021)

The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases
por: Al-Shaiba, R, et al.
Publicado: (2004)

Colorectal cancer and thrombosis
por: Rees, P. A., et al.
Publicado: (2017)

The Role of Cyclooxygenase-2 in Colorectal Cancer
por: Sheng, Juan, et al.
Publicado: (2020)

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
por: Langers, A M J, et al.
Publicado: (2008)

Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction
por: Tran, Jeffrey S., et al.
Publicado: (2021)

MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
por: Langers, A M J, et al.
Publicado: (2012)

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
por: Veronese, M L, et al.
Publicado: (2005)

The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from repeated mechanical loading in female mice
por: Sugiyama, T., et al.
Publicado: (2012)

Association between KRAS mutation and lung metastasis in advanced colorectal cancer
por: Pereira, A A L, et al.
Publicado: (2015)

The role of MYH and microsatellite instability in the development of sporadic colorectal cancer
por: Colebatch, A, et al.
Publicado: (2006)

A retrospective observational study of the relationship between family history and survival from colorectal cancer
por: Morris, E J A, et al.
Publicado: (2013)

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
por: Kämpjärvi, K, et al.
Publicado: (2012)

Hereditary spastic paraplegia initially diagnosed as cerebral palsy
por: Suchowersky, Oksana, et al.
Publicado: (2021)

Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer
por: Doherty, G A, et al.
Publicado: (2009)

Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa
por: Tan, Mario A., et al.
Publicado: (2019)

Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population
por: Bailey, J. A., et al.
Publicado: (2021)

Cellular senescence predicts treatment outcome in metastasised colorectal cancer
por: Haugstetter, A M, et al.
Publicado: (2010)

CDX2 mutations do not account for juvenile polyposis or Peutz–Jeghers syndrome and occur infrequently in sporadic colorectal cancers
por: Woodford-Richens, K L, et al.
Publicado: (2001)

Geographic remoteness and risk of advanced colorectal cancer at diagnosis in Queensland: a multilevel study
por: Baade, P D, et al.
Publicado: (2011)

Colorectal Surgery in COVID-Negative Patients in the Early Phases of the Pandemic: Short-Term Outcomes
por: Stringfield, Sarah B., et al.
Publicado: (2021)

Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis
por: Downing, A, et al.
Publicado: (2013)

Reduction in IGF1 mRNA in the Human Subependymal Zone During Aging
por: Weissleder, Christin, et al.
Publicado: (2019)

Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells
por: Ganesh, Radhakrishnan, et al.
Publicado: (2012)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Thrombocytosis helps to stratify risk of colorectal cancer in patients referred on a 2-week-wait pathway
por: Bailey, J. A., et al.
Publicado: (2020)

Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery
por: Li, L, et al.
Publicado: (2012)

PTEN status in advanced colorectal cancer treated with cetuximab
por: Negri, F V, et al.
Publicado: (2010)

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
por: Petrioli, R, et al.
Publicado: (2004)

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells
por: Morgan, R G, et al.
Publicado: (2015)

Provider-perceived barriers to patient adherence to colorectal cancer screening
por: Zhu, Xuan, et al.
Publicado: (2021)

Adiponectin gene and risk of colorectal cancer
por: Gornick, M C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6okj1f5pogrrqg9v2q6o6kgfni